Enliven Therapeutics (ELVN) Q2 2020 Earnings

14AugExpected
Q3 2019
Q4 2019
Q1 2020
Q2 2020
-4.31
-2.87
-1.44
0

Details

Expected EPS
-0.56
Actual EPS
-0.59
Surprise EPS
-0.03
Surprise Percent
+5.36%

Description

Enliven Therapeutics (ELVN) has reported earnings of -0.59 per share for Q2 2020.

0 Comments

Share your thoughts